The successful trials come after Starlink rival AST SpaceMobile also used its newly launched satellites to power a video call ...

Bluebird bio (BLUE) shares continued their downward descent Monday following news that the company plans to be taken private through a deal valued at up to $96M. Read more here.

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

12 years after going public, beleaguered gene therapy company bluebird bio will be sold to private equity groups Carlyle and ...

JPMorgan upgraded Bluebird Bio (BLUE) to Neutral from Underweight without a price target after the company entered into a definitive agreement ...

Verizon and AST have yet again pushed the boundaries of what can be done with mobile devices by successfully trialing a live ...

Like other developers of recently approved gene therapies, Bluebird has been slow to generate demand for its products. That reflects challenges in securing reimbursement from payers stemming from ...

Beqvez was Pfizer's first gene therapy, stemming from an alliance with Spark Therapeutics (now part of Roche) more than a ...

AST SpaceMobile (NASDAQ: ASTS), a producer of low earth orbit (LEO) satellites for cellular networks, saw its stock soar more ...

D&D London has announced plans to rebrand as the Evolv Collection in April. It comes after the restaurant group was sold to ...

Reimagining Simon Stephens' 2015 play a decade later, Katharine Farmer's new direction of Heisenberg reinterprets the story ...

Kentucky has had its fair share of representation and success on NBC’s “The Voice” including Harlan native Jordan Smith’s win ...